ALL OPTIONS USA, LLC’s Pfizer PFE Stock Holding History

ALL OPTIONS USA, LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-5,167	Closed	-$137K	–	1743
2026 Q2	$124K	Buy	+5,167	New	+$135K	0.02%	632

Other funds holding PFE

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

ALL OPTIONS USA, LLC's PFE Position: Q3 2026 in Review

ALL OPTIONS USA, LLC sold out of Pfizer (PFE) in Q3 2026, closing a stake of 5,167 shares — an estimated $137K sold.

ALL OPTIONS USA, LLC first reported a position in PFE in Q2 2026 and held it in 1 quarter. The position peaked at $124K in Q2 2026. 2,261 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

ALL OPTIONS USA, LLC reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
ALL OPTIONS USA, LLC sold 5,167 Pfizer shares in Q3 2026, an estimated $137K.
ALL OPTIONS USA, LLC first reported a position in Pfizer in Q2 2026 and held it in 1 quarter.
ALL OPTIONS USA, LLC's Pfizer position peaked at $124K in Q2 2026.
2,261 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on ALL OPTIONS USA, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.